Finance

Beta
Lists
531592:BOM
Genpharmasec Ltd
₹1.13
0.00%
(0.00) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531592...
Open
₹1.13
High
₹1.16
Low
₹1.11
Mkt. cap
631.24M
Avg. vol.
395.40K
Volume
204.67K
52-wk high
₹2.20
52-wk low
₹0.75
No. of employees
10
Open
₹1.13
High
₹1.16
Low
₹1.11
Mkt. cap
631.24M
Avg. vol.
395.40K
Volume
204.67K
52-wk high
₹2.20
52-wk low
₹0.75
No. of employees
10
News stories
From sources across the web
About Genpharmasec Ltd
CEO-
Employees10
Founded1992
Headquarters-
SectorTrading company
Websitegenpharmasec.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
120.43M
326.37M
398.28M
554.29M
Cost of goods sold
98.34M
303.76M
377.53M
501.42M
Cost of revenue
98.34M
303.76M
377.53M
501.42M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.50M
11.97M
12.54M
10.69M
Operating expense
15.36M
32.96M
39.78M
39.69M
Total operating expenses
113.69M
336.73M
417.31M
541.11M
Operating income
6.74M
-10.36M
-19.03M
13.18M
Other non operating income
6.95M
4.65M
9.82M
10.16M
EBT including unusual items
12.46M
-7.96M
-13.32M
18.53M
EBT excluding unusual items
12.46M
-7.96M
-13.32M
18.53M
Income tax expense
309.00K
3.80M
-5.00M
5.00M
Effective tax rate
2.48%
-47.76%
37.55%
26.98%
Other operating expenses
9.20M
15.37M
20.58M
22.25M
Net income
12.15M
-11.76M
-4.31M
12.26M
Net profit margin
10.09%
-3.60%
-1.08%
2.21%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.23M
-2.25M
-4.11M
-4.81M
Net interest expenses
-1.23M
-2.25M
-4.11M
-4.81M
Depreciation and amortization charges
2.66M
5.62M
6.65M
6.75M
EBITDA
8.77M
-6.26M
-18.16M
18.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer